Lobeglitazone, a Novel Peroxisome Proliferator-Activated Receptor γ Agonist, Attenuates Renal Fibrosis Caused by Unilateral Ureteral Obstruction in Mice
Kwi-Hyun Bae (Bae KH), Jung Beom Seo (Seo JB), Yun-A Jung (Jung YA), Hye-Young Seo (Seo HY), Sun Hee Kang (Kang SH), Hui-Jeon Jeon (Jeon HJ), Jae Man Lee (Lee JM), Sungwoo Lee (Lee S), Jung-Guk Kim (Kim JG), In-Kyu Lee (Lee IK), Gwon-Soo Jung (Jung GS), Keun-Gyu Park (Park KG)
Endocrinol Metab. 2017;32(1):115-123.   Published online 2017 Feb 28     DOI: https://doi.org/10.3803/EnM.2017.32.1.115
Citations to this article as recorded by Crossref logo
Druggability of lipid metabolism modulation against renal fibrosis
Yuan-yuan Chen, Xiao-guang Chen, Sen Zhang
Acta Pharmacologica Sinica.2022; 43(3): 505.     CrossRef
Lobeglitazone attenuates fibrosis in corneal fibroblasts by interrupting TGF-beta-mediated Smad signaling
Selikem Nuwormegbe, Na-Young Park, Sun Woong Kim
Graefe's Archive for Clinical and Experimental Ophthalmology.2022; 260(1): 149.     CrossRef
Comparative Efficacy of Lobeglitazone Versus Pioglitazone on Albuminuria in Patients with Type 2 Diabetes Mellitus
Kyung-Soo Kim, Sangmo Hong, Hong-Yup Ahn, Cheol-Young Park
Diabetes Therapy.2021; 12(1): 171.     CrossRef
Lobeglitazone: A Novel Thiazolidinedione for the Management of Type 2 Diabetes Mellitus
Jaehyun Bae, Taegyun Park, Hyeyoung Kim, Minyoung Lee, Bong-Soo Cha
Diabetes & Metabolism Journal.2021; 45(3): 326.     CrossRef
Lobeglitazone, A Peroxisome Proliferator-Activated Receptor-Gamma Agonist, Inhibits Papillary Thyroid Cancer Cell Migration and Invasion by Suppressing p38 MAPK Signaling Pathway
Jun-Qing Jin, Jeong-Sun Han, Jeonghoon Ha, Han-Sang Baek, Dong-Jun Lim
Endocrinology and Metabolism.2021; 36(5): 1095.     CrossRef
Protocol for a preclinical systematic review and meta-analysis of pharmacological targeting of peroxisome proliferator-activated receptors in experimental renal injury
William P Martin, Yeong H D Chuah, Emer Conroy, Alison L Reynolds, Conor Judge, Francisco J López-Hernández, Carel W le Roux, Neil G Docherty
BMJ Open Science.2021;[Epub]     CrossRef
Stevioside inhibits unilateral ureteral obstruction‐induced kidney fibrosis and upregulates renal PPARγ expression in mice
Wei Shen, Ke Fan, Ying Zhao, Junyan Zhang, Meilin Xie
Journal of Food Biochemistry.2020;[Epub]     CrossRef
FBW7 Regulates the Autophagy Signal in Mesangial Cells Induced by High Glucose
Chenlin Gao, Fang Fan, Jiao Chen, Yang Long, Shi Tang, Chunxia Jiang, Yong Xu
BioMed Research International.2019; 2019: 1.     CrossRef
Treatment with Lobeglitazone Attenuates Hepatic Steatosis in Diet-Induced Obese Mice
Sorim Choung, Kyong Hye Joung, Bo Ram You, Sang Ki Park, Hyun Jin Kim, Bon Jeong Ku
PPAR Research.2018; 2018: 1.     CrossRef
VCE-004.3, a cannabidiol aminoquinone derivative, prevents bleomycin-induced skin fibrosis and inflammation through PPARγ- and CB2 receptor-dependent pathways
Carmen del Rio, Irene Cantarero, Belén Palomares, María Gómez-Cañas, Javier Fernández-Ruiz, Carolina Pavicic, Adela García-Martín, Maria Luz Bellido, Rafaela Ortega-Castro, Carlos Pérez-Sánchez, Chary López-Pedrera, Giovanni Appendino, Marco A Calzado, Ed
British Journal of Pharmacology.2018; 175(19): 3813.     CrossRef
EHP-101, an oral formulation of the cannabidiol aminoquinone VCE-004.8, alleviates bleomycin-induced skin and lung fibrosis
Adela García-Martín, Martín Garrido-Rodríguez, Carmen Navarrete, Carmen del Río, María L. Bellido, Giovanni Appendino, Marco A. Calzado, Eduardo Muñoz
Biochemical Pharmacology.2018; 157: 304.     CrossRef
Effects of Lobeglitazone, a New Thiazolidinedione, on Osteoblastogenesis and Bone Mineral Density in Mice
Kyoung Min Kim, Hyun-Jin Jin, Seo Yeon Lee, Hyo Jin Maeng, Gha Young Lee, Tae Jung Oh, Sung Hee Choi, Hak Chul Jang, Soo Lim
Endocrinology and Metabolism.2017; 32(3): 389.     CrossRef
Effects of Lobeglitazone, a Novel Thiazolidinedione, on Bone Mineral Density in Patients with Type 2 Diabetes Mellitus over 52 Weeks
Soo Lim, Kyoung Min Kim, Sin Gon Kim, Doo Man Kim, Jeong-Taek Woo, Choon Hee Chung, Kyung Soo Ko, Jeong Hyun Park, Yongsoo Park, Sang Jin Kim, Hak Chul Jang, Dong Seop Choi
Diabetes & Metabolism Journal.2017; 41(5): 377.     CrossRef